2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$12.86+$0.03 (+0.19%)
Price as of Aug 03, 2026 8:54 AM EDT- $571.7MMarket Cap
- -21.77%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$12.86+$0.03 (+0.19%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.83 | ||
Change | -$1.44 (-10.09%) | ||
Open | $13.99 | ||
High | $14.28 | ||
Low | $12.79 | ||
Previous Close | $14.27 | ||
Volume | 2,004,597 | ||
30-Day Average Volume | 1,129,676 | ||
1-Week Change | -19.05% | ||
1-Month Change | -18.12% | ||
1-Year Change | -21.77% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.6M | ||
Total Assets | $292.4M | ||
Market Cap | $571.7M | ||
Enterprise Value | $527.4M | ||
Period: QTR TTM FY | |||
Revenue | $32.0M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$23.4M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $205.0M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 2 | ||
P/E | -24 | ||
PEG | 3 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue